Scene Health Awarded Second NIH Grant to Revolutionize Methadone Treatment, Expand Access
Scene Health (formerly emocha Mobile Health), in collaboration with the University of Washington School of Medicine, was awarded a $1.96M small business innovation research award from the National Institute on Drug Abuse.
- Scene Health (formerly emocha Mobile Health), in collaboration with the University of Washington School of Medicine, was awarded a $1.96M small business innovation research award from the National Institute on Drug Abuse.
- The award funds phase two of a project to revolutionize methadone treatment by expanding access to remote monitoring for opioid use disorder (OUD) through Scene’s video Directly Observed Therapy (video DOT) technology.
- During the pandemic, the Substance Abuse and Mental Health Services Administration (SAMHSA) allowed more take-home methadone doses at the provider's discretion to reduce in-person contact.
- “Currently, SAMHSA’s regulations differentiate between a ‘supervised dose’ and a ‘take-home dose,’” said Sebastian Seiguer, CEO of Scene Health.